Xeomin (another competitor for Botox) was recently FDA approved for the treatment of lines and wrinkles. It is too new to know where this will go. With the approval of Dysport several months ago, this market is getting quite crowded.

Hopefully Xeomin will offer something beneficial to the patient such as longer duration or lower price as compared to Botox and Dysport. Dysport rebates have helped to reduce the costs of wrinkle removal. Hopefully adding another medication in Xeomin will do the same.